adminThe emerging crisis surrounding the ‘Stephen Smoke‘ industry—a pseudonym for products that exist primarily in the regulatory gray zone between traditional commodities and novel consumer technology—is exposing significant vaporware loopholes in state-level legislation. These loopholes allow companies to market products that possess clear public health risks while avoiding established regulatory burdens by defining their offering as “software,” “platform components,” or “future technology,” effectively making them vaporware in a legal sense until a ban is enacted. Tracking the patchwork of state bans reveals a critical legislative lag in addressing speculative and rapidly evolving consumer harms.
The nature of the ‘Stephen Smoke’ industry is often characterized by innovation in delivery mechanisms or marketing, not just the product itself. For example, a new device might be marketed as a “digital wellness system” while facilitating the consumption of unregulated or age-restricted substances. By framing their core offering as the app or the platform that controls the device, rather than the end product, companies exploit vaporware loopholes. They argue that the substance delivery is merely an optional feature of a broader technology package, thus bypassing laws specifically targeting the substance itself. This regulatory sleight-of-hand means that by the time states identify and classify the true nature of the product, widespread consumption has already occurred.
The legislative response has been fragmented, creating a maze of state bans that are difficult to track. Many states are forced to enact highly specific, reactionary legislation that targets a product’s precise chemical compound or mechanical mechanism. This creates an arms race: as soon as one variant of ‘Stephen Smoke’ is banned, the industry releases a slightly modified version—a new flavor, a different chemical analogue, or a slightly altered device—that falls outside the narrow scope of the existing law. These perpetual modifications keep the industry perpetually ahead, exploiting the inherent slowness of the legislative process.
Tracking the efficacy of these state bans highlights the need for fundamental regulatory reform. Instead of banning individual products, legislation must pivot to banning delivery systems or establishing broader classification authority for new product categories that pose a documented public health risk, regardless of their self-proclaimed technological definition. Furthermore, states must enhance cooperation to share intelligence on emerging ‘Stephen Smoke’ variants to prevent companies from simply moving their operations to the next jurisdiction with a vaporware loophole.